Skip to main content

Animations

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    The Michael J. Fox Foundation Launches Initiative to Expedite Development of LRRK2-targeted Therapies and Biomarkers for Parkinson’s Disease

    LRRK2 Investigative Therapeutics Exchange (LITE) will support new approaches targeting LRRK2, the most common cause of inherited PD  Program to focus on bridging basic science advances into…
    Learn more

  • Default content image

    Open-Ocean Row Raises a Record-Breaking $41 Million to Speed Parkinson's Research

    “Team Human Powered Potential’s” open-ocean row, completed on July 19, has raised $41 million for The Michael J. Fox Foundation’s strategic research agenda toward better treatments and a cure for…
    Learn more

  • Default content image

    FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases

    U.S. regulatory agency recognizes potential of alpha-synuclein seed amplification assay (αSyn-SAA) to accelerate clear outcomes in drugmakers’ trials following multi-stakeholder collaboration…
    Learn more

  • Default content image

    Rowers Complete Record-breaking 2,800-mile Open Ocean Row to Benefit Michael J. Fox Foundation, Increase Fundraising Goal to $41 Million

    “Team Human Powered Potential” blows through original $28 million fundraising goal With the original milestone completed, and thanks to the continued generosity of an anonymous donor, an increased…
    Learn more

  • Default content image

    Four Open-Ocean Rowers Embark On 2,800 Mile Cross-Pacific Journey for The Michael J. Fox Foundation and Inspire “Summer Challenge” with an Unprecedented 3:1 Donation Match

    Everyone is invited to cheer on the four-man “Team Human Powered Potential” and join the Foundation’s “Summer Challenge” to help meet our goal of raising a record $28 million for Parkinson’s…
    Learn more

  • Default content image

    Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson’s Disease

    Five research teams have been granted $9.75 million in total funding through The Michael J. Fox Foundation’s ongoing efforts to validate quantitative biomarkers for Parkinson’s disease All funded…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Applauds Passage of National Plan to End Parkinson’s Act in Congress

    NEW YORK (May 23, 2024) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today celebrates the passage of The National Plan to End Parkinson’s Act (H.R.2365/S.1064) in the U.S. Senate…
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.